An observational study in Heart Disease, sponsored by Angiodynamics, Inc.. Completed at 5 sites in United States. Per ClinicalTrials.gov, last updated 2017-12-08.
Sponsored by Angiodynamics, Inc. · Observational
This is a retrospective, record-based study of approximately 100 patients across up to 12 centers within the United States. All patients who have been treated with the AngioVac Venous Drainage Cannula and the Extracorporeal Circuit will be considered for study participation. Eligible subject must meet all of the inclusion criteria and none of the exclusion criteria to be considered enrolled in the study. The purpose of the study is to describe initial experience with the AngioVac Venous Drainage Cannula and the Extracorporeal Circuit.
3,639 studies on the registry are indexed under Heart Diseases; 461 are open to participants now.
This study's enrollment of 51 is below the median of 294 across 1,241 observational studies indexed under Heart Diseases.
Browse Heart Diseases studies →Angiodynamics, Inc. is the lead sponsor of 21 studies on the registry; 8 are open to participants now.
Counted across the registry records on this site, refreshed daily.
patients treated at each study site between February 1, 2013 and February 28, 2015 will be included.
Exclusion Criteria:
Detailing early clinical experience with the AngioVac Venous Drainage Cannula
Time frame: Experience and success is determined immediately after the procedure is completed. No subject follow up data is collected and retrospective data will be reviewed.
This study is completed, as verified in Dec 2017. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Angiodynamics, Inc.